InvestorsHub Logo
Followers 135
Posts 8870
Boards Moderated 1
Alias Born 12/31/2004

Re: None

Thursday, 05/13/2021 10:14:15 PM

Thursday, May 13, 2021 10:14:15 PM

Post# of 21274
After taking the time to really look at the 10Q a few observations.

1) to many add-ons etc. to make a real call on earnings. Derivatives can really have a play on earnings making them good/bad.

2)Professional fees will probably remain high with more acquisitions coming.

3)stock based costs will probably remain high.

4) with the last StarBuds acquisition end of March interest will g up significant next Q.

However, despite this the positives are superior to these costs which will impact the overall bottom line health of SHWZ.

1) Star Buds revenue increased almost 20% this year.

2) Purple Bee's up 300% vrs Y/Y comps.

3)Margins up 8% points.

4)Mesa dispensaries are now SHWZ and expect much higher revenues.

5)EBIDTA forecast to $36 Mil

6)No one can overlook the mention of acquisitions will add much more revenues this year providing they are closed quickly which will greatly increase EBIDTA than forecasted

Would have been a much clearer picture had the CFO included both GAAP and Non GAAP earnings. They are much better than the $3.6 Mil loss.

PS Can't believe the name was a topic of conversation with all the positivity. Waste of ink IMO and absolutely nothing to do with where Dye takes this co. Naming the other labs SCHWAZZ is very telling.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SHWZ News